NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Doctors test Direct-to-Brain cancer treatment in advanced cases
Disease control OngoingThis early-stage study is testing whether delivering immunotherapy drugs directly into the spinal fluid, along with standard intravenous treatment, is safe and effective for patients with advanced lung cancer or melanoma that has spread to the lining of the brain. The trial invol…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New copycat cancer drug faces final test against blockbuster original
Disease control OngoingThis study is testing if a new, potentially more affordable version of the cancer drug Keytruda (called SB27) works just as well for people with advanced non-small cell lung cancer. About 555 participants will receive either the new drug or the original, along with standard chemo…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE3 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC